AmpC β-lactamase: Difference between revisions
From IDWiki
(Created page with "== Background == * Class C serine β-lactamase produced by many Enterobacterales and afermentative Gram-negative bacilli * Production of the β-lactamase may be from: **...") |
No edit summary |
||
| Line 7: | Line 7: | ||
** Plasmid-mediated ''ampC'' genes, including ''bla''<sub>CMY</sub>, ''bla''<sub>FOX</sub>, ''bla''<sub>DHA</sub>, ''bla''<sub>ACT</sub>, and ''bla''<sub>MIR</sub>, and is seen in [[Escherichia coli]], [[Klebsiella pneumoniae]], and [[Salmonella]] |
** Plasmid-mediated ''ampC'' genes, including ''bla''<sub>CMY</sub>, ''bla''<sub>FOX</sub>, ''bla''<sub>DHA</sub>, ''bla''<sub>ACT</sub>, and ''bla''<sub>MIR</sub>, and is seen in [[Escherichia coli]], [[Klebsiella pneumoniae]], and [[Salmonella]] |
||
* Chromosomal de-repression and plasmid-mediated expression are both generally constitutively expressed, so treatment may be guided by initial susceptibility testing |
* Chromosomal de-repression and plasmid-mediated expression are both generally constitutively expressed, so treatment may be guided by initial susceptibility testing |
||
== Inducible AmpC == |
|||
* Bacteria with moderate to high risk of clinically-significant AmpC production includes: |
* Bacteria with moderate to high risk of clinically-significant AmpC production includes: |
||
** [[Enterobacter cloacae]] |
** [[Enterobacter cloacae]] |
||
** [[Klebsiella aerogenes]] |
** [[Klebsiella aerogenes]] |
||
** [[Citrobacter freundii]] |
** [[Citrobacter freundii]] |
||
* The above three species have inducible AmpC in up to 40% of isolates |
|||
** Not necessarily all of the [[SPICE organisms]] |
|||
*Not necessarily all of the [[SPICE organisms]] have risk of inducible AmpC production, of which only about 5% of isolates will have an inducible AmpC |
|||
*Antibiotics that are the best inducers include [[aminopenicillins]] ([[amoxicillin]] and [[ampicillin]]), first-generation [[cephalosporins]], and [[cephamycins]] |
|||
**Also [[imipenem]], though it remains effective even after induction of AmpC overexpression |
|||
*Antibiotics that are weaker inducers include [[piperacillin]], [[ceftriaxone]], [[ceftazidime]], [[cefepime]], and [[aztreonam]] |
|||
[[Category:Β-lactamases]] |
[[Category:Β-lactamases]] |
||
Latest revision as of 20:17, 24 November 2021
Background
- Class C serine β-lactamase produced by many Enterobacterales and afermentative Gram-negative bacilli
- Production of the β-lactamase may be from:
- Inducible chromosomal resistance, often following a few doses of ceftriaxone or ceftazidime
- Stable chromosomal de-repression, often seen in Escherichia coli and Shigella
- Plasmid-mediated ampC genes, including blaCMY, blaFOX, blaDHA, blaACT, and blaMIR, and is seen in Escherichia coli, Klebsiella pneumoniae, and Salmonella
- Chromosomal de-repression and plasmid-mediated expression are both generally constitutively expressed, so treatment may be guided by initial susceptibility testing
Inducible AmpC
- Bacteria with moderate to high risk of clinically-significant AmpC production includes:
- The above three species have inducible AmpC in up to 40% of isolates
- Not necessarily all of the SPICE organisms have risk of inducible AmpC production, of which only about 5% of isolates will have an inducible AmpC
- Antibiotics that are the best inducers include aminopenicillins (amoxicillin and ampicillin), first-generation cephalosporins, and cephamycins
- Also imipenem, though it remains effective even after induction of AmpC overexpression
- Antibiotics that are weaker inducers include piperacillin, ceftriaxone, ceftazidime, cefepime, and aztreonam
